| Literature DB >> 15207063 |
Tuomas Jartti1, Pasi Lehtinen, Tytti Vuorinen, Riika Osterback, Bernadette van den Hoogen, Albert D M E Osterhaus, Olli Ruuskanen.
Abstract
We studied the viral etiology of acute expiratory wheezing (bronchiolitis, acute asthma) in 293 hospitalized children in a 2-year prospective study in Finland. A potential causative viral agent was detected in 88% of the cases. Eleven different viruses were represented. Respiratory syncytial virus (RSV) (27%), enteroviruses (25%), rhinovirus (24%), and nontypable rhino/enterovirus (16%) were found most frequently. In infants, RSV was found in 54% and respiratory picornaviruses (rhinovirus and enteroviruses) in 42% of the cases. In older children, respiratory picornaviruses dominated (65% of children ages 1-2 years and 82% of children ages > or =3 years). Human metapneumovirus was detected in 4% of all children and in 11% of infants. To prevent and treat acute expiratory wheezing illnesses in children, efforts should be focused on RSV, enterovirus, and rhinovirus infections.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15207063 PMCID: PMC3323183 DOI: 10.3201/eid1006.030629
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Hospitalized children with expiratory wheezing during the study period. Black indicates included patients.
Positive viral findings in 293 children hospitalized for acute expiratory wheezinga
| Virus | Virus antigen test; n = 293 | Virus culture; n = 292 | Virus PCR;b n = 291 | Virus serology; n = 266 | Total; n = 293 |
|---|---|---|---|---|---|
| Respiratory syncytial virus (RSV) | 62 (21) | 58 (20) | 50 (18) | 56 (21) | 80 (27) |
| Enterovirus | 14 (5) | 59 (20) | 27 (10) | 72 (25) | |
| Rhinovirus | 25 (9) | 65 (22) | 71 (24) | ||
| Rhino/enterovirus | 1 (0.3) | 46 (16) | 46 (16) | ||
| Parainfluenza virus type 1 | 8 (3) | 0 | 8 (3) | ||
| Parainfluenza virus type 2 | 0 | 0 | 0 | 0 | |
| Parainfluenza virus type 3 | 4 (1) | 1 (0.3) | 5 (2) | ||
| Parainfluenza virus type 1 or 3 | 8 (3) | 4 (1) | |||
| Adenovirus | 0 | 9 (3) | 6 (2) | 15 (5) | |
| Human metapneumovirus | 12 (4) | 12 (4) | |||
| Influenza A virus | 1 (0.3) | 1 (0.3) | 2 (0.8) | 3 (1) | |
| Influenza B virus | 4 (1) | 2 (0.7) | 2 (0.8) | 4 (1) | |
| Coronavirus | 0 | 4 (1) | 4 (1) | ||
| Mixed viral infection |
|
|
|
| 57 (19) |
| Total | 79 (27) | 111 (38) | 236 (81) | 101 (38) | 258 (88) |
aData are presented as number of samples positive (% of evaluated samples). bFor RSV polymerase chain reaction (PCR), n = 279.
Figure 2The epidemics of respiratory syncytial virus (red), rhinovirus (blue), enterovirus (green), and human metapneumovirus (brown) during the study period.
Figure 3The prevalence of respiratory viruses in hospitalized, wheezing children in different age groups. RSV, respiratory syncytial virus; RHINO, rhinovirus; RHI-ENT, rhino/enterovirus; ENTERO, enteroviruses; HMPV, human metapneumovirus; PARA 1–3, parainfluenza virus types 1–3; INFLU A/B, influenza A and B viruses; ADENO, adenovirus; CORONA, coronavirus; MIXED, mixed viral infection. p values are for intergroup comparisons: RSV p < 0.001, HMPV p = 0.003, enteroviruses p = 0.0018, and adenovirus p = 0.022.
Viral etiology of acute expiratory wheezing in childrena,b
| Y of study | Wheezing episodes | Age (y) | Methods for virus detection | Viral identification rates (%) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Culture | Antigen | Serology | PCR | RSV | Rhino | Entero | PIV types 1–3 | Influ A/B | Adeno | Corona | HMPV | Total pos. | |||
| 1965 ( | 225 | 0–16 | + | 8 | 3 | 5 | 4 | 0 | 4 | 27 | |||||
| 1971 ( | 855 | 0–14 | + | 9 | 2 | 1 | 8 | 1 | 2 | 25 | |||||
| 1975 ( | 1,515 | 0–12 | + | 3 | 12 | 3 | 3 | 2 | 1 | 23 | |||||
| 1976 ( | 267 | 1–12 | + | 4 | 6 | 1 | 1 | 1 | 3 | 14 | |||||
| 1979 ( | 1,851 | 0–15 | + | 7 | 1 | 6 | 2 | 21 | |||||||
| 1979 ( | 554 | 0–12 | + | 2 | 13 | 4 | 4 | 2 | 1 | 26 | |||||
| 1979 ( | 72 | 5–15 | + | 1 | 28 | 3 | 10 | 1 | 49 | ||||||
| 1984 ( | 256 | 2–15 | + | + | 5 | 4 | 2 | 3 | 2 | 29 | |||||
| 1987 ( | 204 | 0–12 | + | + | 6 | 1 | 5 | 0 | 3 | 2 | 19 | ||||
| 1993 ( | 99 | 0.2–16 | + | + | 14 | 19 | 3 | 0 | 2 | 0 | 36 | ||||
| 1996 ( | 181 | 0.3–2 | + | + | 12 | 6 | 1 | 7 | 2 | 26 | |||||
| 1999 ( | 70 | 0.2–16 | + | + | 26 | 61 | 1 | 1 | 4 | 83 | |||||
| 1999 ( | 132 | 0.3–14 | + | 21 | 47 | 10 | 4 | 5 | 5 | 5 | 82 | ||||
| 2000 ( | 84 | 0.7 | + | 54 | 10 | 8 | 0 | 0 | 13 | 0 | 74 | ||||
| 2002 ( | 118 | 0–1.5 | 53 | 21 | 3 | 3 | 8 | 3 | 74 | ||||||
| 2003 ( | 179 | 0.1–17 | + | + | 7 | 79 | 1 | 2 | 2 | 88 | |||||
aSampling period of at least 12 mo. bRSV, respiratory syncytial virus; PCR, polymerase chain reaction; rhino, rhinovirus; entero, enterovirus; PIV, parainfluenza virus; influ, influenza virus; adeno, adenovirus; corona, coronavirus; HMPV, human metapnemovirus; pos., positive.